Clinical Trials Directory

Trials / Completed

CompletedNCT03353909

The Efficacy of A New Crosslinked Hyaluronan Gel in Prevention of Intrauterine Adhesion

The Efficacy of A New Crosslinked Hyaluronan Gel in the Prevention of Postoperative Intrauterine Adhesion After Dilatation and Curettage in Women With Delayed Miscarriage: A Prospective, Randomized, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
BioRegen Biomedical (CHangzhou) Co., Ltd · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Using American Fertility Society classification of intrauterine adhesions, the efficacy of a new crosslinked hyaluronan gel in reducing intrauterine adhesion formation after dilatation and curettage for delayed miscarriage in women without previous dilatation and curettage was examined.

Detailed description

Study Objectives: To evaluate the efficacy of a new crosslinked hyaluronan gel in reducing intrauterine adhesions formation after dilatation and curettage. Design: Randomized controlled trial. Settings: Six hospitals for maternal and child health care in China. Patients: Three hundred women undergoing dilatation and curettage for delayed miscarriage without previous dilatation and curettage. Interventions: Women were randomly assigned into either dilatation and curettage alone group or dilatation and curettage plus new crosslinked hyaluronan gel application group with 1:1 allocation. Measurements and Outcomes: All patients were evaluated using American Fertility Society classification of IUAs during the follow-up diagnostic hysteroscopy, scheduled 3 months after dilatation and curettage procedure. The primary outcome was the number of women with IUAs, and the secondary outcome was the adhesion scores and the severity of IUAs.

Conditions

Interventions

TypeNameDescription
DEVICEnew crosslinked hyaluronan gelAt the end of the dilatation and curettage, new crosslinked hyaluronan gel was applied to the uterine cavity.

Timeline

Start date
2016-07-01
Primary completion
2017-02-15
Completion
2017-02-15
First posted
2017-11-27
Last updated
2017-11-27

Source: ClinicalTrials.gov record NCT03353909. Inclusion in this directory is not an endorsement.